Ascendis Pharma A/S ADR (NASDAQ:ASND) currently has a daily average trading volume of 491.80K but it saw 288936 shares traded in last market. With a market cap of 10.31B USD, the company’s current market price of $170.71 came falling about -1.27 while comparing to the previous closing price of $172.90. In past 52 weeks, the stock remained buoying in the range of price level as high as $183.00 and as low as $111.09. In the recent trading on the day, stock has struck highest price mark of $170.49 while lowest mark touched by it was $175.28.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Morgan Stanley which upgraded the stock as “Overweight” in its note to investors issued on May 05, 2025, recommending a price target of $250 for it. UBS issued its recommendations for the stock as it initiated the price target for the stock is $196.
Over the week, ASND’s stock price is moving -0.59% down while it is 6.47% when we observe its performance for the past one month. Year-to-date it is 24.00% up and over the past year, the stock is showing an upside performance of 33.74%.
Currently, Ascendis Pharma A/S ADR’s total number of outstanding shares is 60.37M. Company’s return on investment (ROI) stands at -203.02%. It has a 81.19 of forward P/E ratio. Stock’s beta reads 0.36. Stock has a price to sale or P/S ratio amounts to 26.15. Its return on asset (ROA) is -36.49% on average.
